Cargando…
Recurrent Left Ventricular Thrombus Formation on Rivaroxaban Therapy in Cardiomyopathy and Liver Cirrhosis
Left ventricular (LV) thrombus in patients with reduced LV systolic function carries significant thromboembolic risk. Direct oral anticoagulants are an attractive alternative to warfarin for LV thrombus management. However, there are not enough data regarding the safety and efficacy of direct oral a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302174/ https://www.ncbi.nlm.nih.gov/pubmed/34317005 http://dx.doi.org/10.1016/j.jaccas.2020.05.094 |
_version_ | 1783726837187215360 |
---|---|
author | Ghani, Usman Wiley, Karlo A. Singhal, Raman Sanina, Cristina |
author_facet | Ghani, Usman Wiley, Karlo A. Singhal, Raman Sanina, Cristina |
author_sort | Ghani, Usman |
collection | PubMed |
description | Left ventricular (LV) thrombus in patients with reduced LV systolic function carries significant thromboembolic risk. Direct oral anticoagulants are an attractive alternative to warfarin for LV thrombus management. However, there are not enough data regarding the safety and efficacy of direct oral anticoagulants for the treatment of LV thrombus. (Level of Difficulty: Beginner.) |
format | Online Article Text |
id | pubmed-8302174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83021742021-07-26 Recurrent Left Ventricular Thrombus Formation on Rivaroxaban Therapy in Cardiomyopathy and Liver Cirrhosis Ghani, Usman Wiley, Karlo A. Singhal, Raman Sanina, Cristina JACC Case Rep Mini-Focus Issue: Heart Failure Left ventricular (LV) thrombus in patients with reduced LV systolic function carries significant thromboembolic risk. Direct oral anticoagulants are an attractive alternative to warfarin for LV thrombus management. However, there are not enough data regarding the safety and efficacy of direct oral anticoagulants for the treatment of LV thrombus. (Level of Difficulty: Beginner.) Elsevier 2020-08-19 /pmc/articles/PMC8302174/ /pubmed/34317005 http://dx.doi.org/10.1016/j.jaccas.2020.05.094 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Mini-Focus Issue: Heart Failure Ghani, Usman Wiley, Karlo A. Singhal, Raman Sanina, Cristina Recurrent Left Ventricular Thrombus Formation on Rivaroxaban Therapy in Cardiomyopathy and Liver Cirrhosis |
title | Recurrent Left Ventricular Thrombus Formation on Rivaroxaban Therapy in Cardiomyopathy and Liver Cirrhosis |
title_full | Recurrent Left Ventricular Thrombus Formation on Rivaroxaban Therapy in Cardiomyopathy and Liver Cirrhosis |
title_fullStr | Recurrent Left Ventricular Thrombus Formation on Rivaroxaban Therapy in Cardiomyopathy and Liver Cirrhosis |
title_full_unstemmed | Recurrent Left Ventricular Thrombus Formation on Rivaroxaban Therapy in Cardiomyopathy and Liver Cirrhosis |
title_short | Recurrent Left Ventricular Thrombus Formation on Rivaroxaban Therapy in Cardiomyopathy and Liver Cirrhosis |
title_sort | recurrent left ventricular thrombus formation on rivaroxaban therapy in cardiomyopathy and liver cirrhosis |
topic | Mini-Focus Issue: Heart Failure |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302174/ https://www.ncbi.nlm.nih.gov/pubmed/34317005 http://dx.doi.org/10.1016/j.jaccas.2020.05.094 |
work_keys_str_mv | AT ghaniusman recurrentleftventricularthrombusformationonrivaroxabantherapyincardiomyopathyandlivercirrhosis AT wileykarloa recurrentleftventricularthrombusformationonrivaroxabantherapyincardiomyopathyandlivercirrhosis AT singhalraman recurrentleftventricularthrombusformationonrivaroxabantherapyincardiomyopathyandlivercirrhosis AT saninacristina recurrentleftventricularthrombusformationonrivaroxabantherapyincardiomyopathyandlivercirrhosis |